Dudediligence.

Xenon Pharmaceuticals Inc

XENENASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$22.0M

15 notices · 381,589 sh

Oct 2025 to Oct 2026

Reported ·

$20.9M

23 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

All 23 reported sales carry the 10b5-1 box. Together they are 0.38% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-28: CHRISTOPHER KENNEY, Form 1442026-08-11: STEVEN GANNON, Form 1442026-06-05: GILLIAN CANNON, Form 1442026-06-05: GARY PATOU, Form 1442026-03-13: CHRISTOPHER JOHN KENNEY, Form 1442026-03-13: ANDREA DIFABIO, Form 1442026-03-13: IAN MORTIMER, Form 1442026-03-10: ANDREA DIFABIO, Form 1442026-03-10: CHRISTOPHER JOHN KENNEY, Form 1442026-03-10: IAN MORTIMER, Form 1442026-03-09: IAN MORTIMER, Form 1442026-01-02: IAN MORTIMER, Form 1442025-12-08: IAN MORTIMER, Form 1442025-12-05: IAN MORTIMER, Form 1442025-11-28: IAN MORTIMER, Form 1442025-11-28: MORTIMER IAN, sold2025-12-05: MORTIMER IAN, sold2026-01-02: MORTIMER IAN, sold2026-03-09: MORTIMER IAN, sold2026-03-10: DiFabio Andrea, sold2026-03-10: KENNEY CHRISTOPHER JOHN, sold2026-03-13: MORTIMER IAN, sold2026-03-13: DiFabio Andrea, sold2026-03-13: KENNEY CHRISTOPHER JOHN, sold2026-06-05: Cannon Gillian, sold2026-06-05: PATOU GARY, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-28CHRISTOPHER KENNEY, Chief Medical Officer$437,721
7,068 shplan 2026-05-29Form 4s on file end Jun 23144 ↗
2026-08-11STEVEN GANNON, Director$640,553
10,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-05GILLIAN CANNON, Director$63,058
1,190 shplan 2025-08-15144 ↗
Form 4, 2026-06-08: sold 1,190 at $53.14 Form 4 ↗
2026-06-05GARY PATOU, Director$70,053
1,322 shplan 2025-08-17144 ↗
Form 4, 2026-06-08: sold 1,322 at $53.14 Form 4 ↗
2026-03-13CHRISTOPHER JOHN KENNEY, Chief Medical Officer$77,867
1,410 shplan 2025-12-03144 ↗
Form 4, 2026-03-13: sold 1,410 at $55.23 Form 4 ↗
2026-03-13ANDREA DIFABIO, Chief Legal Officer$74,112
1,342 shplan 2025-12-03144 ↗
Form 4, 2026-03-13: sold 1,342 at $55.23 Form 4 ↗
2026-03-13IAN MORTIMER, PRESIDENT & CEO$403,583
7,308 shplan 2025-12-03144 ↗
Form 4, 2026-03-13: sold 7,308 at $55.23 Form 4 ↗
2026-03-10ANDREA DIFABIO, Chief Legal Officer$156,702
2,607 shplan 2025-12-03144 ↗
Form 4, 2026-03-11: sold 2,607 at $60.11 Form 4 ↗
2026-03-10CHRISTOPHER JOHN KENNEY, Chief Medical Officer$166,559
2,771 shplan 2025-12-03144 ↗
Form 4, 2026-03-11: sold 2,771 at $60.11 Form 4 ↗
2026-03-10IAN MORTIMER, PRESIDENT & CEO$677,357
11,269 shplan 2025-12-03no Form 4 on file144 ↗
2026-03-09IAN MORTIMER, PRESIDENT & CEO$16.3M
270,000 shplan 2024-09-27144 ↗
Form 4, 2026-03-11: sold 281,269 at $60.32 Form 4 ↗
2026-01-02IAN MORTIMER, PRESIDENT & CEO$1,777,166
40,000 shplan 2024-09-27144 ↗
Form 4, 2026-01-02: sold 40,000 at $44.43 Form 4 ↗
2025-12-08IAN MORTIMER, PRESIDENT & CEO$495,248
10,830 shplan 2024-09-27no Form 4 on file144 ↗
2025-12-05IAN MORTIMER, PRESIDENT & CEO$647,360
14,375 shplan 2024-09-27144 ↗
Form 4, 2025-12-09: sold 25,205 at $45.33 Form 4 ↗
2025-11-28IAN MORTIMER, PRESIDENT & CEO$4,366
97 shplan 2024-09-27144 ↗
Form 4, 2025-12-03: sold 97 at $45.01 Form 4 ↗